Use of Kantakari Avaleha for Treating Cough in Children

A Clinical Study to Evaluate the Efficacy of Kantakari Avaleha in Management of Kasa Roga w.s.r. Cough due to Various etiology in Children

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107660

Enrollment

Registered

2026-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient with Cardinal features of Kasa Roga Patients having Caough (on and off) for last 6 months

Exclusion criteria

Exclusion criteria: Patients of age below 5 years and above 12 years Patient having cough less than 6 months Patients having congenital deformity Patient requiring hospitalization for the management of disease Patient requiring any surgical intervention Patient having chronic infectious disease like Tuberculosis , Bronchial asthama , AIDS

Design outcomes

Primary

Measure	Time frame
To assess the reduction in frequency and severity of cough in children treated with Kantakari AvalehaTimepoint: 21 days	—

Secondary

Measure	Time frame
To evaluate improvement in associated symptoms of Kasa (e.g.-Sputum, Throat irritation, Hoarseness) Timepoint: 21 days;To assess improvement in sleep disturbance due to coughTimepoint: 21 days;To evaluate changes in respiratory findings (wheeze, crepitations)Timepoint: 21 days	—

Countries

India

Contacts

Public ContactProf Dr Ritesh Murlidhar Kela

Shri Dhanwantri Ayurvedic Medical College And Research Centre

drriteshkela@gmail.com9881259158

Outcome results